Anthelmintics are a group of drugs used to treat infections caused by parasitic worms, including roundworms, tapeworms, and flukes. These drugs work by either killing the worms or by inhibiting their growth and reproduction.

There are several classes of anthelmintics, including benzimidazoles, nicotinic agonists, and macrocyclic lactones. Each class of drugs has a different mechanism of action and is effective against different types of worms.

Anthelmintics are commonly used in both humans and animals to treat a variety of infections. In humans, they are used to treat infections caused by intestinal worms, such as ascariasis, hookworm infection, and trichuriasis. They may also be used to treat infections caused by tissue-dwelling worms, such as filariasis.

In animals, anthelmintics are used to treat a variety of infections caused by parasites, including lungworms, liver flukes, and tapeworms. These drugs are commonly used in livestock to prevent and control parasitic infections, which can cause significant economic losses.

While anthelmintics are generally considered safe and effective, they can have side effects, particularly if used in high doses or for prolonged periods. Common side effects include nausea, vomiting, and abdominal pain. In rare cases, more serious side effects, such as liver and kidney damage, may occur. It is important to follow dosage instructions carefully and to consult a healthcare provider or veterinarian if you have any concerns about the use of anthelmintics.

Global Market:

Anthelmintics are drugs used to treat infections caused by parasitic worms, such as roundworms, tapeworms, and flukes. The global market for anthelmintics is a significant segment of the pharmaceutical industry, given the high prevalence of parasitic worm infections in humans and livestock.

According to a report by Grand View Research, the global market for anthelmintics was valued at USD 1.8 billion in 2020 and is expected to reach USD 2.6 billion by 2028, growing at a CAGR of 4.6% during the forecast period (2021-2028).

The market for anthelmintics is segmented into various categories based on drug class, including benzimidazoles, nicotinic agonists, macrocyclic lactones, and others. Macrocyclic lactones are the largest segment of the market, followed by benzimidazoles.

The market is also segmented by geography, with North America and Europe accounting for the largest market shares due to the high prevalence of parasitic worm infections in livestock and the availability of major pharmaceutical companies. The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, driven by increasing awareness and access to healthcare, as well as rising disposable income.

The demand for anthelmintics is driven by several factors, including the increasing prevalence of parasitic worm infections in humans and livestock, the growing demand for animal-derived products, and the availability of effective treatments. Additionally, the rise in healthcare expenditure and the increasing availability of reimbursement policies are also contributing to the growth of the market.

However, the market for anthelmintics is also facing challenges such as the emergence of drug-resistant parasites, which is limiting the effectiveness of existing treatments and driving the need for the development of new anthelmintics. Moreover, the high cost of developing and producing new drugs and the stringent regulatory requirements for approval are also impacting the market growth.

Overall, the market for anthelmintics is expected to continue growing in the coming years, driven by the increasing demand for effective treatments for parasitic worm infections and advancements in drug development technology, while also taking into account the need to balance the benefits with the risks of drug resistance.

ALSO READ Drugs and Drug Targets Drug Discovery, Design and Development Pharmacokinetics and Pharmacodynamics Computer Aided Drug Design Drug Metabolism Pharmaceutical Biotechnology Combinatorial Chemistry Novel Drug Delivery Systems Formulations Natural Products Traditional Medicine Drug Repurposing and Drug Repositioning Precision Medicine Personalized Therapies Drug Development and Clinical Trials Biomarker Discovery and Development Biologics and Biosimilars Vaccines and Immunotherapies Steam Cells and Regenerative Medicine Drug Safety and Pharmacovigilance Pharmacogenomics Toxicology Rare Diseases Receptors as Target for Drug Discovery Drugs Affecting the Cardiovascular System Drugs Affecting the Central Nervous System Drugs Affecting Hormonal Systems Chemotherapeutic Agents Antibacterial Agents Antiviral Agents Anticancer Agents The Opioid Analgesics Anti-Ulcer Agents Non-Steroidal Anti Inflammatory Drugs Steroids Antibiotics Antineoplastic Agents Anthelmintics Sulphonamides Artificial Intelligence and Machine Learning in Drug Discovery and Development Genomics and Proteomics in Drug Discovery and Development Gene Therapy and Genome Editing in Treating Genetic Diseases Nanotechnology in Drug Delivery and Imaging Virtual and Augmented Reality in Drug Discovery and Development Patient Engagement and Patient-Centered Drug Development Big Data Analytics in Drug Discovery and Development

Medicinal Chemistry Conferences 2023 Canada Pharmacology Conferences Medicinal Chemistry Conferences Medicinal Chemistry Conferences 2023 Drug Design Conferences Traditional Medicine Conferences Medicinal Chemistry Conferences 2023 Middle East Natural Products Conferences